WithdrawnNot Applicable

OTX-14-002: Device Exposure Registry

Stopped: On going discussions with FDA

Plain-language summary

The objective of the study is to collect post-approval data relative to the incidence of endophthalmitis for cataract surgery patients treated with the FDA-approved ReSure Sealant when used by a broad group of physicians under commercial use conditions

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

All patients that receive at least one application of the ReSure Sealant on the operative eye following cataract surgery will be enrolled.

What they're measuring

Occurrence of endophthalmitis

Timeframe: Day 30

Trial details

NCT IDNCT02309736

SponsorOcular Therapeutix, Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2020-04

View on ClinicalTrials.gov More Endophthalmitis trials